Self-driving cars just got a whole lot more interesting…
Chinese developers have unveiled a car that can be controlled, get this, with your mind.
How does that work? New advancements in human telepathy?
It’s actually much simpler than that.
The equipment worn by the drive can read signals that can direct the car in any direction, lock and unlock, and stop… all without using your hands or feet.
You see, there are sensors that pick up EEG signals from the driver’s brain, and the computer program picks which signals are meant to be used, and enables the car to be driven.
Now, the initial thinking here is that this technology would allow people with disabilities to drive cars easier.
It’s a great concept, but as of now the prototype can only drive forward.
Unfortunately, there are no plans to mass-produce this car — not yet, at least.
In other words, it’s going to take quite a bit of testing and research to get it right, which is not to mention the fact that drivers might be hesitant to operate a vehicle like this (for obvious reasons).
People may fear that the distraction while wearing sensors that send thought signals would result in a car accident. Granted, this is a fair concern considering the nature of the technology. Developers aren’t too worried, however, since concentration is only needed while changing how the vehicle moves, as in changing lanes or making turns.
To continue reading, click here to read the Reuters article.
Until next time,
Keith Kohl
Check us out on YouTube!A true insider in the technology and energy markets, Keith’s research has helped everyday investors capitalize from the rapid adoption of new technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the Managing Editor of Energy & Capital, as well as the investment director of Angel Publishing’s Energy Investor and Technology and Opportunity.
For nearly two decades, Keith has been providing in-depth coverage of the hottest investment trends before they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on key advancements in robotics and AI technology.
Keith’s keen trading acumen and investment research also extend all the way into the complex biotech sector, where he and his readers take advantage of the newest and most groundbreaking medical therapies being developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s to lab scientists grinding out the latest medical technology and treatments. You can join his vast investment community and target the most profitable biotech stocks in Keith’s Topline Trader advisory newsletter.
